Current Neuropharmacology
Title:Editorial (Thematic Issue: Epigenetics and Neuro-behavioral Modulations)
Volume: 14 Issue: 1
Author(s): István Bókkon and Birendra Nath Mallick
Affiliation:
Export Options
About this article
Cite this article as:
Bókkon István and Mallick Nath Birendra, Editorial (Thematic Issue: Epigenetics and Neuro-behavioral Modulations), Current Neuropharmacology 2016; 14 (1) . https://dx.doi.org/10.2174/1570159X1401160122124901
DOI https://dx.doi.org/10.2174/1570159X1401160122124901 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
34
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Sevoflurane But Not Propofol Provided Dual Effects of Cell Survival in Human Neuroblastoma SH-SY5Y Cells
Current Alzheimer Research Effects of Static Magnetic Fields on Blood Pressure in Animals and Humans
Current Hypertension Reviews Hepatocyte Growth Factor (HGF): Neurotrophic Functions and Therapeutic Implications for Neuronal Injury/Diseases
Current Signal Transduction Therapy Nerve Conduction Through Dendrites via Proton Hopping
Current Computer-Aided Drug Design Ketamine for Chronic Pain and Treatment Resistant Depression: A Mechanistic Hypothesis
Current Drug Therapy Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Editorial (Thematic Issue: GABAergic Modulation as Treatment Strategy: Consideration of Several Diseases)
Current Pharmaceutical Design Recent Patents in Diagnosis and Treatment for Inborn Errors of Metabolism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) From Preclinical to Clinical Trials: An Update on Potential Therapies for Huntington’s Disease
Current Psychopharmacology Nanoparticles in Melanoma
Current Medicinal Chemistry A Review of the Effects of Hypoxia, Sleep Deprivation and Transcranial Magnetic Stimulation on EEG Activity in Humans: Challenges for Drug Discovery for Alzheimer's Disease
Current Alzheimer Research Pharmacological Activation of p53 in Cancer Cells
Current Pharmaceutical Design Structural Basis of the Dysfunctioning of Human 2-Oxo Acid Dehydrogenase Complexes
Current Medicinal Chemistry The Physiology and Pathophysiology of a Novel Angiotensin Receptor-binding Protein ATRAP/Agtrap
Current Pharmaceutical Design Cholinesterases and Cholinesterase Inhibitors
Current Enzyme Inhibition Editorial [Hot Topic: Glutamate Receptors and Related Processes as Drug Targets (Guest Editor: Michel Baudry)]
Current Drug Targets An Update on Drug Interactions with the Herbal Medicine Ginkgo biloba
Current Drug Metabolism Systemic Adverse Drug Reactions Secondary to Anti-VEGF Intravitreal Injection in Patients with Neovascular Age-Related Macular Degeneration
Current Vascular Pharmacology Vagus nerve stimulation in treating depression: A tale of two stories.
Current Molecular Medicine Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review
Current Neuropharmacology